Vaccine developer SK Bioscience shares debut at double IPO price

SK Bioscience Co

18/03/2021 24:02

SEOUL, March 18 (Reuters) - Shares of South Korean vaccine
developer SK Bioscience Co Ltd  302440.KS  debuted at double its
IPO price on Thursday, as investors chased South Korea's biggest
IPO in nearly four years. 
    SK Bioscience shares opened at 130,000 won, compared to an
initial public offering (IPO) price of 65,000 won per share
earlier this month, at the top of its indicative range.
 urn:newsml:reuters.com:*:nL4N2L61XB

 (Reporting by Joyce Lee and Jihoon Lee; Editing by Christopher
Cushing)
 ((jungyoon.lee@tr.com; +82 2 6936 1467;))